Psychiatry and Neurology, Epilepsy · Bethesda, MD
NPI
1194712208
Since 2005
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
6410 Rockledge Dr Ste 610
Bethesda, MD, 20817
Phone (301) 530-9745
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
660 services
Medicare patients, 2024
381
Average age 74
Drug cost, 2024
$1.1M
1,470 prescriptions
Company payments, 2025
$2,819
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan Ross was code 99214 (office e&m - established), 123 times for 103 patients. In total Jonathan Ross billed 660 services in 25 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 123 | 103 | $109.91 | $14K |
| 95816 Neurologic | Facility | 81 | 78 | $51.11 | $4,140 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 78 | 73 | $15.23 | $1,188 |
| 99222 Hospital E&M - Initial | Facility | 66 | 64 | $117.86 | $7,779 |
| 99223 Hospital E&M - Initial | Facility | 44 | 43 | $159.22 | $7,005 |
| 99233 Hospital E&M - Subsequent | Facility | 35 | 29 | $109.22 | $3,823 |
| 99215 Office E&M - Established | Office | 31 | 28 | $155.72 | $4,827 |
| 99204 Office E&M - New | Office | 27 | 27 | $135.99 | $3,672 |
| 99232 Hospital E&M - Subsequent | Facility | 25 | 21 | $72.57 | $1,814 |
| 93040 Electrocardiogram | Office | 22 | 16 | $12.49 | $275 |
| 99291 Critical Care E&M | Facility | 15 | 13 | $187.59 | $2,814 |
| 93042 Electrocardiogram | Facility | 13 | 13 | $6.15 | $79.95 |
By year: 2022 $155K for 1,186 services; 2023 $182K for 1,287 services; 2024 $82K for 660 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan Ross prescribed most often to Medicare patients was Levetiracetam, with 207 prescriptions and refills. In total Jonathan Ross wrote 1,470 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 207 | 348 | 42 | $8,818 |
| Lacosamide Generic | 95 | 103 | 17 | $8,867 |
| Gabapentin Generic | 89 | 119 | 20 | $1,312 |
| Lamotrigine Generic | 87 | 123 | Under 11 | $1,352 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 85 | 174 | 23 | $3,495 |
| Topiramate Generic | 67 | 80 | Under 11 | $592 |
| Briviact Brivaracetam | 42 | 43 | Under 11 | $58K |
| Nourianz Istradefylline | 39 | 59 | Under 11 | $114K |
| Nortriptyline Hcl Generic | 37 | 55 | Under 11 | $422 |
| Xcopri Cenobamate | 33 | 33 | Under 11 | $42K |
| Memantine Hcl Generic | 32 | 49 | Under 11 | $716 |
| Pregabalin Generic | 31 | 33 | Under 11 | $1,938 |
| Kesimpta Pen Ofatumumab | 30 | 36 | Under 11 | $335K |
| Clonazepam Generic | 29 | 29 | Under 11 | $246 |
| Amitriptyline Hcl Generic | 26 | 38 | Under 11 | $263 |
Brand drugs: 255 claims; generic drugs: 1,215 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan Ross $2,819 ($2,819 in general payments such as food, travel and fees) from 25 companies. The largest payer was Novartis Pharmaceuticals Corporation with $992.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 10 | $992 |
| SK Life Science, Inc. | 12 | $401 |
| UCB, Inc. UCB.BR | 7 | $226 |
| Amneal Pharmaceuticals LLC AMRX | 5 | $125 |
| Argenx US, Inc. ARGX | 4 | $117 |
| Lundbeck LLC | 4 | $93.33 |
| Amgen Inc. AMGN | 3 | $86.29 |
| Abbvie Inc. ABBV | 1 | $85.09 |
| Harmony Biosciences LLC HRMY | 2 | $81.92 |
| Axsome Therapeutics, Inc. AXSM | 3 | $75.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.